AAPL $339.50 -1.03% ▼ ACN $239.12 +1.27% ▲ ADBE $256.73 +4.12% ▲ ADEA $21.30 +1.04% ▲ ADIG $15.97 +4.93% ▲ ADP $292.75 +1.99% ▲ ADSK $245.58 +2.37% ▲ AEHR $61.99 -1.60% ▼ AEVA $10.27 +3.42% ▲ AGYS $116.40 +3.72% ▲ AI $11.69 +3.91% ▲ AIP $19.76 +3.56% ▲ ALAB $284.80 -0.93% ▼ ALKT $14.66 +4.64% ▲ ALNT $92.95 -0.78% ▼ AMBA $63.22 +0.73% ▲ AMBQ $50.98 +1.96% ▲ AMD $534.74 -0.77% ▼ AMPL $15.70 +3.43% ▲ AMZN $262.63 -0.22% ▼ ANET $181.19 -1.41% ▼ AOSL $23.03 +1.90% ▲ APLD $19.33 -0.06% ▼ APP $272.46 +1.25% ▲ APPN $44.51 +5.27% ▲ APPS $9.80 +3.15% ▲ ARM $221.06 -3.13% ▼ ARRY $3.33 +2.95% ▲ ARW $214.93 -0.62% ▼ ASML $1,630.84 -1.07% ▼ AAPL $339.50 -1.03% ▼ ACN $239.12 +1.27% ▲ ADBE $256.73 +4.12% ▲ ADEA $21.30 +1.04% ▲ ADIG $15.97 +4.93% ▲ ADP $292.75 +1.99% ▲ ADSK $245.58 +2.37% ▲ AEHR $61.99 -1.60% ▼ AEVA $10.27 +3.42% ▲ AGYS $116.40 +3.72% ▲ AI $11.69 +3.91% ▲ AIP $19.76 +3.56% ▲ ALAB $284.80 -0.93% ▼ ALKT $14.66 +4.64% ▲ ALNT $92.95 -0.78% ▼ AMBA $63.22 +0.73% ▲ AMBQ $50.98 +1.96% ▲ AMD $534.74 -0.77% ▼ AMPL $15.70 +3.43% ▲ AMZN $262.63 -0.22% ▼ ANET $181.19 -1.41% ▼ AOSL $23.03 +1.90% ▲ APLD $19.33 -0.06% ▼ APP $272.46 +1.25% ▲ APPN $44.51 +5.27% ▲ APPS $9.80 +3.15% ▲ ARM $221.06 -3.13% ▼ ARRY $3.33 +2.95% ▲ ARW $214.93 -0.62% ▼ ASML $1,630.84 -1.07% ▼

Can you see everything?

October 20, 2026 · by TPW Pipeline

What are we looking at, and who wants us to see it? | Image: A24

This review contains spoilers.

I have heard it said that of all the drugs, fame is the most addictive. For Elizabeth Holmes, at least, I am willing to believe that is true. It is the only explanation for You Can See Everything, a movie that is, at its core, about several varieties of manipulation.

Holmes, as the CEO of Theranos, was a business-world celebrity: a woman who’d built a private company valued at $9 billion around a miniaturized blood testing platform that supposedly let people test just a drop of blood for a variety of ailments. She had a deal with Walgreens, speaking gigs, a New Yorker profile, a cover story in Fortune; Fox Ne …

Read the full story at The Verge.

Source: www.theverge.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.

Stocks in this story